Hepatitis C virus encodes two enveloped glycoproteins, E1 and E2, which 2 are involved in viral attachment and entry into target cells. We have obtained in 3 insect cells infected by recombinant baculovirus a chimeric secreted recombinant 4 protein, E1 341 E2 661, containing the ectodomains of E1 and E2. The described 5 procedure allows the purification of approximately 2 mg of protein from 1 L of 6 culture media. Sedimentation velocity experiments and SDS-PAGE in the absence 7 of reducing agents indicate that the protein has a high tendency to self-associate, the 8 dimer being the main species observed. All the oligomeric forms observed maintain 9 a conformation which is recognized by the conformation-dependent monoclonal 10 antibody H53 directed against the E2 ectodomain. The spectroscopic properties of 11 E1 341 E2 661 are those of a three-dimensionally structured protein. Moreover, the 12 chimeric protein is able to bind to human antibodies present in HCV-positive human 13 sera. Accordingly, this chimeric soluble polypeptide chain may be a valuable tool to 14 study the structure-function relationship of HCV envelope proteins. 15 16
Introduction 1
Hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, 2 and hepatocellular carcinoma worldwide [1] . This enveloped and positive-stranded 3 RNA virus belongs to the Hepacivirus genus of the Flaviviridae family [2] . There is 4 no vaccine for HCV, and current antiviral therapies are based on the use of 5 polyethylene glycol-modified interferon in combination with ribavirin. However, 6 these treatments are expensive, relatively toxic, and effective in only half of the 7 treated patients [3] . 8 Structural and non-structural viral proteins are produced by cleavage of a 9 polyprotein precursor by both host cell signal peptidases and viral proteinases [4, 5] . 10 The envelope glycoproteins, E1 and E2 are classified as type I integral 11 transmembrane proteins with a N-terminal ectodomain and a C-terminal hydrophobic 12 anchor domain. During their synthesis, the ectodomains of HCV envelope 13 glycoproteins are targeted to the endoplasmic reticulum lumen, where they are highly 14 modified by N-linked glycosylation [6] . In vitro expression studies have shown that 15 both glycoproteins associate to form a stable heterodimer, which accumulate in the 16 endoplasmic reticulum, the proposed site for HCV assembly and budding [7] . 17
This heterodimer is thought to be the functional complex at the surface of the 18 virus [7] , being involved in the virus entry into the cell. E2 seems to be the protein 19 responsible for the interaction with cell receptors that include the CD81 tetraspanin, 20 the scavenger receptor BI (SR-BI) and Claudin-1, a tight junction protein that 21 recently has been proposed as co-receptor in a late step for HCV entry [8] [9] [10] . Also, 22 E2 elicits production of neutralizing antibodies against the virus, and is involved in 23 viral morphogenesis [9, 11] . Antibodies specific for epitopes within one of the 24 hypervariable regions of E2 have been reported to inhibit binding of E2 to cells and 25
Protein samples were digested with N-glycosidase F (PNGase F, Roche). 1 Digestion was carried out for 16 h at 37 ºC in 20 mM sodium phosphate, pH 7.0, 50 2 mM EDTA, and 1% (p/v) octylglucoside. Digested samples were mixed with 3X 3 Laemmli sample buffer and analyzed by SDS-PAGE. The proteins were stained with 4
Coomassie brilliant blue R 250. The proteins were also transferred to nitrocellulose 5 membranes that were subsequently incubated with the lectin concanavalin A 6 conjugated to biotin. The glycoproteins were detected using HRP-streptavidin at a 7 1:1000 dilution. 8 9
Circular Dichroism 10
CD measurements were carried out on a Jasco spectropolarimeter, model J-11
All the measurements were conducted at 25 ºC with cells thermostated with a 12
Neslab RTE-111 water bath. Far-UV CD spectrum was measured at a protein 13 concentration of 0.15 mg/ml using protein dialyzed against 20 mM Tris-HCl pH 7, 50 14 mM NaCl. The pathlength was 1 mm. Five scans were averaged for each 15 measurements and the contribution of the buffer was always subtracted. The spectra 16 were calculated by using 110 as the mean residue molecular mass and the results are 17 expressed in terms of residue molar ellipticity in degcm 2 dmol -1 . The secondary 18 structure of the protein was evaluated by computer fit of the dichroism spectra 19 according to Convex Constraint Analysis (CCA) [35] . This method relies on an 20 algorithm that calculates the contribution of the secondary structure elements that 21
give rise to the original spectral curve without referring to spectra from model 22 systems. The secondary structure was also predicted by the GOR IV method [36] . 23 
24

Fluorescence spectroscopy 25
Emission spectra were obtained at 25 ºC using an SLM AMINCO 8000C 1 spectrofluorimeter, fitted with a 450-W xenon arc. Excitation and emission slit widths 2 were set at 4 nm. The protein concentration was 0.05 mg/ml and a 0.4 x 1 cm cuvette 3 was used. Buffer was 20 mM Tris-HCl pH 7, 50 mM NaCl. Excitation was performed 4 at 275 or 295 nm, and the emission spectra were recorded over the range 285-450 nm. 5
The contribution of the buffer was always subtracted. The tyrosine contribution to the 6 emission spectra was calculated by subtracting the emission spectrum measured at 7  exc = 295 nm multiplied by a factor from that measured at  exc = 275 nm. The factor 8 was obtained from the ratio between the fluorescence intensities measured with  exc = 9 275 and  exc = 295 nm at wavelengths above 380 nm, where there is no tyrosine 10 contribution. 11
12
Analytical ultracentrifugation 13
The sedimentation velocity experiments were carried out on a Beckman 14 Optima XL-A analytical ultracentrifuge equipped with UV-VIS optics detection 15 system, using an An60Ti rotor and 12 mm double-sector centerpieces. The 16 experiments were done with a protein concentration of 5 M. They were carried out 17 at 20 ºC. The buffer employed was 20 mM Tris-HCl pH 7, 50 mM NaCl. carbonate-bicarbonate buffer, pH 9.6. Unbound antigen was washed out, and the 3 wells were blocked with 3% non-fat dry milk in PBS for 60 min at room temperature. 4
After washing the wells were incubated at 37ºC for 2 h with HCV-positive and 5 negative human sera. Seven positive and seven negative sera were used at a dilution 6 with TBS-NP-40. After the last step, they were washed three times with this buffer 5 and once with distilled water. The precipitates were then boiled for 5 min in SDS-6 PAGE sample buffer and analyzed on a 12% polyacrylamide gel. After 7 electrophoresis and transfer to nitrocellulose membranes, protein E1 341 E2 661 was 8 detected by incubating the membranes with a polyclonal goat anti-E2 antibody 9
(USBiological) at a 1:500 dilution followed with a rabbit anti-goat antibody 10 conjugated to HRP diluted at 1:3000. The peroxidase reaction was developed with 11 due to the cloning strategy, the FLAG sequence between E1 and E2 and the His tags 5 used to purify the recombinant protein (Fig. 1) In a homologous recombination event, the E1 341 E2 661 gene was inserted into the viral 9 genome. The protein was expressed by infecting a new batch of insect cells using 10 amplified recombinant virus. Cells were grown and protocols were carried out as 11 described in Materials and methods. The analysis of the different fractions with a 12 HRP conjugate anti-His antibody showed that the protein was produced soluble both 13 intracellularly and in the extracellular medium ( Fig. 2A, lanes 1, 2) . Moreover, after 14 cell lysis by sonication, it was observed that the protein was also able to form 15 insoluble inclusion bodies ( Fig. 2A, lane 3) . Only the protein which was expressed in 16 a soluble form and secreted to the extracellular medium was subsequently purified 17 using affinity chromatography on a Ni-nitrilotriacetic acid-agarose column (Fig. 2B) . 18
The protein that elutes with 200 mM imidazole was determined to be > 95% pure by 19 densitometry of stained SDS gels. We have used sedimentation velocity to determine the oligomeric nature of 23 E1 341 E2 661 (Fig. 4) . The calculated molecular mass of the most abundant species was 24 150 kDa with a sedimentation coefficient of 7s. Considering that the expected 25 molecular mass of the E1 341 E2 661 monomer determined by SDS-PAGE is 64 kDa, the 1 main form observed by ultracentrifugation is compatible with a dimer (Fig. 4, peak  2 b). However, the recombinant protein was also present as monomer (Fig. 4 , peak a) 3 and higher order oligomers formed by more than two units of monomers, such us 4 trimers (peak c), tetramers (peak d) and other higher forms (peaks e, f and others not 5 shown) (Fig. 4) . Based on the area under each peak the following proportion of each 6 form was estimated: 13% monomer, 31 % dimer, 17% trimer and 13% tetramer. The 7 analysis of the recombinant protein by SDS-PAGE in the absence of reducing agents 8 also indicated the oligomeric nature of the purified protein (Fig. 4, inset) . Under these 9 conditions only monomers, dimers and trimers were observed while a high 10 percentage of the protein does not enter into the gel. 11
12
Spectroscopic analysis of E1 341 E2 661 13
The spectroscopic characterization of E1 341 E2 661 was carried out by means of 14 circular dichroism and fluorescence spectroscopies. The far-UV CD spectrum of 15 E1 341 E2 661 showed a minimum at 208 nm and a shoulder at 223 nm (Fig. 5) . 16
Deconvolution of this spectrum using the program Convex Constraint Analysis 17 (CCA) [35] yielded the following percentages of secondary structure elements: 13% 18 -helix, 48% -sheet, and 39% non-ordered structure. The predictive GOR IV 19 method [36], which is based upon the propensity of each amino acid to adopt a 20 particular secondary structure, yielded similar results: 8% -helix, 32% -sheet and 21 60% non-ordered structure. 22
The fluorescence emission spectrum of E1 341 E2 661 is depicted in Figure 6 . 23
Upon excitation at both 275 and 295 nm, the recombinant protein exhibited a 24 maximum at 331 nm. The shape of the spectrum indicates that the fluorescence of 25 this protein is highly dominated by tryptophan residues. In fact, the difference 1 between the fluorescence spectra obtained upon excitation at 275 and 295 nm, the 2 latter being normalized, indicates that the contribution of tyrosine residues to the 3 recombinant protein fluorescence upon excitation at 275 nm was very low, 4 approximately 5%. The position of the maximum indicates that the tryptophan 5 residues occupy a relatively low hydrophobic environment. When the protein is 6 treated with 8 M urea, the fluorescence intensity increased by 15% and the maximum 7 is red shifted to 345 nm (Fig. 6) . 8 9 Antigenic characterization of E1 341 E2 661 
10
A panel of seven HCV-positive and seven HCV-negative human sera was 11 used to assess the antigenic properties of E1 341 E2 661 . The recombinant protein was 12 able to bind under native conditions to antibodies present in all seven positive sera 13 tested as assessed by ELISA (Fig. 7, sera 1-7) . The values of the absorbance at 492 14 nm were much higher than those obtained with the negative controls (Fig. 7, serum 8 ; 15 only one negative serum is depicted). Moreover, the difference in the values of the 16 absorbance is consistent with the HCV titer as determined by COBAS TaqMan HCV 17 test [40] (data not shown). On the other hand, the same sera were used in 18 immunoblotting experiments after protein separation by SDS-PAGE (Fig. 7, inset) . 19
The data were quantified by densitometry. The volumes were normalized with respect 20 to that obtained with serum 3 which gave the highest value (Figure 7, inset) . There 21 was no correlation between these values and those obtained by ELISA. Thus, sera 1, 22 4 and 7 which are among the ones that gave the highest absorbance values in ELISA 23
were the ones which yielded the lowest volume values (approximately 30% of that of 24 serum 3 which, on the other hand, yielded one of the lowest values in ELISA). This is 25 indicative of the existence of both continuous and discontinuous epitopes, the latter 1 being the ones which are lost under denaturing conditions. 2
The conformation of the chimeric protein was examined by 3 immunoprecipitation with the monoclonal anti-E2 antibody H53, and with a 4 monoclonal antibody anti-E1. The E1 341 E2 661 protein was efficiently 5 immunoprecipitated by both antibodies. Since H53 is a conformation-dependent 6 monoclonal antibody, it can be assumed that the E2 moiety of the chimeric 7 recombinant protein possesses a native-like conformation. When the 8 immunoprecipitated protein was analyzed by SDS-PAGE in the absence of reducing 9 agents, the same pattern of bands shown in the inset of Figure 4 , lane 2 was observed. 10
In consequence it can be stated that all the oligomeric forms were able to react with 11 the monoclonal antibody. The recombinant protein was able to bind to Huh7 cells and 12 when the binding was performed in the presence of anti-CD81 it was drastically 13 reduced (data not shown). 14 In order to distinguish the presence of anti-E1 and anti-E2 antibodies in the 15 sera of infected individuals, an inhibition experiment using a polyclonal anti-E2 661 16 antibody was carried out (Fig. 8) , although their patterns of 21 inhibition are markedly different (Fig. 8A) . To assure maximum inhibition, the rest of 22 the sera were mixed with a 10 -1 dilution of the anti-E2 661 antibody. At this value, 23 inhibition studies showed that the polyclonal anti-E2 661 antibody blocked the binding 24 of the IgGs from the seven HCV-positive sera to different levels (Fig. 8B) , the 25 average being of inhibition 72 % (Fig. 8, horizontal line) . To assess the presence of 1 both anti-E1 and anti-E2 IgGs in the serum of the infected individuals, the same 2 experiment was carried out in the presence of an excess of monoclonal anti-E1 and 3 using sera 3 and 5 as examples. When these sera were incubated with a 10 -1 dilution 4 of monoclonal anti-E1, an 80% inhibition was observed for serum 3 while only a 5 15% inhibition was observed for serum 5. Thus, serum 3 would contain mainly 6 antibodies which bind to E1 while those antibodies present in serum 5 would bind to 7 E2. Consequently, and although the number of sera may not be statistically 8 significant, the response to each envelope protein would depend on the infected 9 individual. We have also expressed the same sequence both in E. coli and yeast cells 13 (data not shown). The protein was produced in bacteria in a really high yield as an 14 insoluble 50 kDa polypeptide but all attempts to solubilize it failed. In this respect, 15 although it has been recently described the purification and application of bacterially 16 expressed chimeric protein E1E2 [52], after purification in the presence of 6 M urea, 17 the protein had to be dialyzed in the presence of both 0.1% Triton X-100 and 0.2% 18 BSA which precludes any subsequent structural study. By using the yeast Pichia 19 pastoris a highly glycosylated and insoluble non secreted protein was obtained. 20
Taken together, these facts indicate that the proper glycosylation is an indispensable 21 factor for the global folding of this structural protein. In fact, it has been reported that 22 the glycans of HCV envelope glycoproteins play a major role in protein folding 23 and/or in HCV entry [53] [54] [55] . 24
22
The E1 341 E2 661 protein used throughout this study was secreted to the cellular 1 medium by virus-infected insect cells. However, it was also produced intracellularly 2 in both soluble and insoluble forms which were more heterogeneous in size than the 3 secreted one. This may be indicative that only the properly folded and processed 4 polypeptide chains are able to enter the secretion pathway. On the other hand, the E1 5 and E2 ectodomains are separated by a hydrophilic sequence which contains the 6 FLAG sequence with the enterokinase cleavage sequence which could be used to 7 obtain both domains in a separate and soluble form. Nevertheless, all attempts to 8 cleave that peptide bond failed. 9
The deconvolution of the circular dichroism far-UV spectrum of the 10 recombinant E1 341 E2 661 protein showed that -sheet is the major ordered secondary 11 structure element. The percentages of secondary structure deduced from the CD 12 spectrum are coincident with those deduced from the amino acid sequence. 13
Moreover, the fluorescence emission maximum corresponding to the tryptophan 14 residues of the protein is centered at 331 nm, indicating that these residues are 15 located in a moderately hydrophobic environment. Upon denaturation with urea, this 16 maximum is red-shifted to 345 nm which is the value described for Trp residues in 17 aqueous solution. Besides, the quantum yield of Trp residues undergoes a 18 considerable increase which would indicate that the Trp fluorescence is quenched by 19 nearby residues in the native conformation but not in the open and denatured 20 conformation observed in the presence of urea. In consequence, the spectroscopic 21 properties of the secreted protein are those of a three-dimensionally structured 22 protein. 23 We have also evaluated the ability of E1 341 E2 661 to bind to human antibodies 24 with a panel of HCV-positive human sera by both ELISA and immunoblotting. 25
Under the conditions employed in ELISA assays the recombinant protein maintains 1 its native conformation and the IgGs recognize both lineal and discontinous epitopes. protein is the fact that it was also able to bind to human hepatome Huh7 cells through 7 CD81 which has been described as a cellular receptor. 
